Week
|
BL
|
Tx
|
W24
|
W25
|
W26
|
W27
|
W28
|
W30
|
W34
|
W38
|
W42
|
W46
|
W52
|
---|
Informed consent
|
X
| | | | | | | | | | | | |
Medical history
|
X
|
X
| | | | | | | | | | | |
Transplantation information
| |
X
| | | | | | | | | | | |
Concomitant medication
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Physical examination
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Routine lab
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Urinalysis
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
CMV, EBV and BK viral load
| | |
X
|
X
| |
X
| |
X
| |
X
| |
X
|
X
|
MSC infusion
| | | |
X
|
X
| | | | | | | | |
Renal biopsy
| |
X
|
X
| | | | | | | | | |
X
|
Iohexol clearance
| | |
X
| | | | | | | | | |
X
|
Immune monitoring
| |
X
|
X
|
Xa
|
Xa
|
X
| | |
X
| | | |
X
|
DSA
|
X
|
X
|
X
| | | | |
X
| | | | |
X
|
Safety assesment
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
-
BL baseline, Tx renal transplantation
-
abefore and 4 h after MSC infusion